A pilot, open-label, 8-week study evaluating the efficacy of adjunctive minocycline for the treatment of bipolar I/II depression

被引：0
|
作者：
Soczynska, J. [1 ]
Kennedy, S. H. [1 ]
Alsuwaidan, M.
Mansur, R. [1 ]
Li, M. [1 ]
McAndrews, M. P. [1 ]
Brietzke, E.
Taylor, V.
McIntyre, R. S. [1 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2014年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-41-008
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [1] A pilot, open-label, 8-week study evaluating the efficacy of adjunctive minocycline for the treatment of bipolar I/II depression
    Soczynksa, J.
    Kennedy, S. H.
    Alsuwaidan, M.
    Mansur, R.
    Li, M.
    McAndrews, M. P.
    Brietzke, E.
    Taylor, V.
    McIntyre, R. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S445 - S446
  • [2] A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression
    Soczynska, Joanna K.
    Kennedy, Sidney H.
    Alsuwaidan, Mohammad
    Mansur, Rodrigo B.
    Li, Madeline
    McAndrews, Mary Pat
    Brietzke, Elisa
    Woldeyohannes, Hanna O.
    Taylor, Valerie H.
    McIntyre, Roger S.
    BIPOLAR DISORDERS, 2017, 19 (03) : 198 - 213
  • [3] Open-label pilot study of adjunctive aripiprazole treatment for difficult to treat bipolar depression
    Metrick, M. S.
    Anand, A.
    BIPOLAR DISORDERS, 2008, 10 : 38 - 38
  • [4] An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression
    DeKarske, Daryl
    Alva, Gustavo
    Aldred, Jason L.
    Coate, Bruce
    Cantillon, Marc
    Jacobi, Lori
    Nunez, Rene
    Norton, James C.
    Abler, Victor
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1751 - 1761
  • [5] Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study
    Ahearn, EP
    Mussey, M
    Johnson, C
    Krohn, A
    Krahn, D
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (01) : 29 - 33
  • [6] A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder
    El Hage, Cynthia
    Ghabrash, Maykel E.
    Dubreucq, Simon
    Brissette, Suzanne
    Lesperance, Francois
    Lesperance, Paul
    Ouellet-Plamondon, Clairelaine
    Bruneau, Julie
    Jutras-Aswad, Didier
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (05) : 268 - 273
  • [7] Adjunctive ziprasidone for resistant depression: 8-week pilot study
    Dunner, DL
    Amsterdam, JD
    Shelton, RC
    Loebel, A
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 92S - 92S
  • [8] Adjunctive ziprasidone for resistant depression: 8-week pilot study
    Dunner, D
    Amsterdam, JD
    Shelton, RC
    Loebel, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S444 - S444
  • [9] The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study
    Lee, Hwang-Bin
    Yoon, Bo-Hyun
    Kwon, Young-Joon
    Woo, Young Sup
    Lee, Jung-Goo
    Kim, Moon-Doo
    Bahk, Won-Myong
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 743 - 753
  • [10] The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study
    Hwang-Bin Lee
    Bo-Hyun Yoon
    Young-Joon Kwon
    Young Sup Woo
    Jung-Goo Lee
    Moon-Doo Kim
    Won-Myong Bahk
    Clinical Drug Investigation, 2013, 33 : 743 - 753
12345